SCHEMBL17880375

SCHEMBL17880375

CC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.50
▸ DPP8 Q6V1X1 2/20 0.50
▸ DPP9 Q86TI2 2/20 0.50
▸ BMP1 P13497 3/20 0.47
▸ BLM P54132 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ BACE1 P56817 7/20 0.41
▸ CTSD P07339 2/20 0.41
▸ GRM8 O00222 1/20 0.41
▸ GRM6 O15303 1/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GSR P00390 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ GRIK1 P39086 1/20 0.41
▸ GRM5 P41594 1/20 0.41
▸ GRIA1 P42261 1/20 0.41
▸ GRIA2 P42262 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14553975 1.00 DPP4 (0.50) DPP4DPP8DPP9BMP1BLM
SCHEMBL15451422 0.94 DPP4 (0.55) DPP4DPP8DPP9BMP1BLM
SCHEMBL14669854 0.94 DPP4 (0.55) DPP4DPP8DPP9BMP1BLM
SCHEMBL17915897 0.94 DPP4 (0.55) DPP4DPP8DPP9BMP1BLM
SCHEMBL13467398 0.94 DPP4 (0.55) DPP4DPP8DPP9BMP1BLM
SCHEMBL16297654 0.91 DPP4 (0.58) DPP4DPP8DPP9BMP1BLM
SCHEMBL17192782 0.88 SIRT5 (0.50) BMP1BLMALOX15SIRT5FOLH1
SCHEMBL29706692 0.88 FOLH1 (0.51) DPP4DPP8DPP9BMP1BLM
SCHEMBL29636521 0.88 FOLH1 (0.51) DPP4DPP8DPP9BMP1BLM
SCHEMBL30596280 0.88 FOLH1 (0.51) DPP4DPP8DPP9BMP1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663555-B2 Beta sheet tapes ribbons in tissue engineering UNIVERSITY OF LEEDS (GB) 2017-05-30 — — US disclosed
US-20160340392-A1 BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING UNIVERSITY OF LEEDS (GB) 2016-11-24 — — US disclosed
US-9447151-B2 Beta sheet tapes ribbons in tissue engineering THE UNIVERSITY OF LEEDS (GB) 2016-09-20 — — US disclosed
US-20160185824-A1 BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING UNIVERSITY OF LEEDS (GB) 2016-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340392-A1 BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING IAPP, TAGLN2, KRT18 DPP4 1820/4885DPP8 1204/4885DPP9 1560/4885
US-20160185824-A1 BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING IAPP, TAGLN2, KRT18 DPP4 1820/4885DPP8 1204/4885DPP9 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback